Bristol-Myers Squibb (BMY) Earnings Call Transcripts

Price: $60.28
Market Cap: $122.33B
Avg Volume: 11.93M
Country: US
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.436
52W Range: $39.35-63.33
Website: Bristol-Myers Squibb

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-02-06 $1.47 $1.67
Read Transcript Q3 2024 2024-10-31 $1.49 $1.80
Read Transcript Q2 2024 2024-07-26 $1.62 $2.07
Read Transcript Q1 2024 2024-04-25 $-4.41 $-4.40
Read Transcript Q4 2023 2024-02-02 $1.52 $1.70
Read Transcript Q3 2023 2023-10-26 $1.76 $2.00
Read Transcript Q2 2023 2023-07-27 $1.99 $1.75
Read Transcript Q1 2023 2023-04-27 $1.98 $2.05
Read Transcript Q4 2022 2023-02-02 $1.71 $1.82
Read Transcript Q3 2022 2022-10-26 N/A N/A
Read Transcript Q2 2022 2022-07-27 $1.79 $1.93
Read Transcript Q1 2022 2022-04-29 $1.92 $1.96
Read Transcript Q4 2021 2022-02-04 $1.83 $1.83
Read Transcript Q3 2021 2021-10-27 $1.91 $2.00
Read Transcript Q2 2021 2021-07-28 $1.88 $1.93
Read Transcript Q1 2021 2021-04-29 $1.80 $1.74
Read Transcript Q4 2020 2021-02-04 $1.37 $1.46
Read Transcript Q3 2020 2020-11-05 $1.49 $1.63
Read Transcript Q2 2020 2020-08-06 $1.46 $1.63
Read Transcript Q1 2020 2020-05-07 $1.48 $1.72
Read Transcript Q4 2019 2020-02-06 $1.30 $1.22
Read Transcript Q3 2019 2019-10-31 $1.06 $1.17
Read Transcript Q2 2019 2019-07-25 $1.06 $1.18
Read Transcript Q1 2019 2019-04-25 $1.09 $1.10
Read Transcript Q4 2018 2019-01-24 $0.85 $0.94
Read Transcript Q3 2018 2018-10-25 $0.91 $1.09
Read Transcript Q2 2018 2018-07-26 $0.87 $1.01
Read Transcript Q1 2018 2018-04-26 $0.85 $0.94
Read Transcript Q4 2017 2018-02-05 $0.67 $0.68
Read Transcript Q3 2017 2017-10-26 $0.77 $0.75
Read Transcript Q2 2017 2017-07-27 $0.73 $0.74
Read Transcript Q1 2017 2017-04-27 $0.74 $0.84
Read Transcript Q4 2016 2017-01-26 $0.67 $0.63
Read Transcript Q3 2016 2016-10-27 $0.65 $0.77
Read Transcript Q2 2016 2016-07-28 $0.67 $0.69
Read Transcript Q1 2016 2016-04-28 $0.65 $0.74

Related Metrics

Explore detailed financial metrics and analysis for BMY.